Abstract
Background Consumption of breast milk substitutes (BMS) by children aged under six months in low and middle income countries (LMICs) is directly driven by country income and family wealth. Multi-country investigations on the consumption of BMS by older children (6–23 months) are lacking.
Methods Using data from 86 nationally representative surveys carried out in LMICs from 2010 onwards, we analyzed the prevalence of continued breastfeeding at one and two years, and frequency of consumption of formula and other non-human milk by age in months. Indicators were estimated through 24-hour dietary recall. Absolute and relative wealth indicators were used to describe within- and between-country socioeconomic inequalities. Results were stratified by country income groups.
Findings Breastfeeding declined sharply as children became older in all LMICs, especially in upper-middle income countries. Formula consumption peaked at six months of age in low and lower-middle income countries, and at around 12 months in upper-middle income countries. Consumption of formula at any age higher in children from wealthier families in all countries, while breastfeeding was more common among poor children. Multilevel linear regression analysis showed that consumption of formula was positively associated while breastfeeding was negatively associated with absolute national income. Factors at country level explained a substantial proportion of overall variability in formula use and breastfeeding.
Interpretation Infant and young child feeding practices vary strongly according to wealth, both within and between countries. Breastfeeding falls sharply as children become older, especially in wealthier families living in upper-middle income countries; this is also the group with highest formula consumption at any age. Country-level factors play an important role in explaining BMS consumption by all family wealth groups in LMICs, suggesting that formula marketing at national level may be partly responsible for the observed differences.
Funding The Bill & Melinda Gates Foundation, through the WHO
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was funded by The Bill and Melinda Gates Foundation, through the World Health Organization (grant numbers: OPP1179886/ INV 007594) and the Associacao Brasileira de Saude Coletiva. PARN was supported by the Brazilian National Council for Scientific and Technological Development (grant number: 155541/2018 8).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study is based on anonymous publicly available datasets, so any ethical clearance was the responsibility of the national institutes in charge of data collection
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
paugustorn{at}gmail.com
abarros{at}equidade.org
phil.baker{at}deakin.edu.au
ellen.piwoz{at}gatesfoundation.org
tmelo{at}equidade.org
giovagatica{at}gmail.com
juliana.vaz{at}gmail.com
rollinsn{at}who.int
cvictora{at}gmail.com
Data Availability
All data can be obtained accessing the websites of each organization in charge of data collection and disclosure.
